Deep experience
to guide your innovation

Xontogeny’s team has experience across scientific diligence, drug and medical technology development and operations from preclinical stages through commercialization. Through the efforts of the team, Xontogeny supports and stays connected with its entrepreneurs and larger community of collaborators by providing strategic and investment leadership to create successful outcomes across its portfolio of companies.


Chris Garabedian

Chris Garabedian

Chairman & CEO
Fred Callori

Fred Callori

SVP, Corporate Development
Ben Askew

Ben Askew, Ph.D.

Partner, Research & Development
Shobha Parthasarathi

Shobha Parthasarathi, Ph.D.

VP, External Innovation & New Ventures

Iva Toudjarska, Ph.D.

VP, Portfolio Operations

Ellen Travers

VP, Talent Acquisition
Wendy Cort

Wendy Cort

Director, Administration
Gianna Hoffman-Luca

Gianna Hoffman-Luca, Ph.D.

Senior Associate

Brad Murray

Senior Associate
Heather Petty

Heather Petty

Senior Manager, Program Development

Susanna Harris, Ph.D.

Manager, Engagement & Communications

Jayanth Batchu



Chris Garabedian

Chris Garabedian founded Xontogeny in June of 2016 to support multiple promising technologies from early development through clinical proof of concept.

Joe Edelman

Joe Edelman founded the hedge fund Perceptive Advisors, LLC in 1999, to further the progress of promising companies within the life sciences industry.

Adam Stone

Adam Stone joined Perceptive Advisors, a hedge fund focused on supporting the progress of the life sciences industry, in 2006.